Aciphex
Product Images NDC 62856-243

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Aciphex (NDC 62856-243). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eisai Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Aciphex Is Available For Oral Administration As Delayed-release, Enteric-coated Tablets Containing 20 mg Of Rabeprazole Sodium. (Aciphex 01)

Chemical structure of the active ingredient likely present in AcipHex, showing a complex molecule with aromatic rings, nitrogen atoms, a sulfoxide group, and a methoxyethoxy side chain.*

FDA Label Image

Mean Daytime Heartburn Scores Rab-usa-2 (Aciphex 02)

Line chart comparing mean heartburn scores over a 28-day study period among placebo, Rabeprazole 10 mg, and Rabeprazole 20 mg groups, with study days on the x-axis and heartburn scores on the y-axis, where lower scores indicate reduced severity.*

FDA Label Image

Mean Nighttime Heartburn Scores Rab-usa-2 (Aciphex 03)

A line graph depicting mean heartburn scores over a 28-day study period for AcipHex (Rabeprazole) at 10 mg and 20 mg doses compared to placebo. The y-axis shows mean scores from 0 (none) to 4 (very severe), and the x-axis represents study days from -14 to 28. Scores decrease over time, showing treatment effect after day 0.*

FDA Label Image

Mean Daytime Heartburn Scores Rab-usa-3 (Aciphex 04)

Line graph depicting mean heartburn scores over a 28-day study period comparing AcipHex (Rabeprazole 20 mg) to placebo. The x-axis shows study days from -14 to 28, and the y-axis shows mean heartburn scores from 0 (none) to 4 (very severe). The graph shows a notable decrease in scores for AcipHex after study day 0 compared to placebo.*

FDA Label Image

Mean Nighttime Heartburn Scores Rab-usa-3 (Aciphex 05)

A line chart comparing mean heartburn scores over a 28-day study period between two groups: placebo (n=58) and AcipHex 20 mg (labeled as RAB 20mg, n=59). The x-axis represents study days from -14 to 28, and the y-axis shows mean heartburn scores from 0 (none) to 4 (very severe). The chart illustrates a decrease in mean heartburn scores over time for both groups, with the AcipHex group maintaining lower scores post-day 0.*

FDA Label Image

Principal Display Panelndc 62856-243-30aciphexrabeprazole Sodiumdelayed- Releasetablets20 mg30 Tabletsrx Only (Aciphex 06)

AcipHex 20 mg delayed-release tablets label featuring the active ingredient rabeprazole sodium. The label shows packaging for 30 tablets, distributed by Eisai Inc. It includes dosage storage instructions, a barcode, and NDC 62856-243-30. The tablets are marked Rx only and made in Japan.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.